Citations

Clear

1432 citation(s) found for "Uk, Nathan".

Effect of peri‐operative pharmacological interventions on postoperative delirium in patients having cardiac surgery: a systematic review and Bayesian network meta‐analysis
Queiroz, Ivo , Tavares, Arthur, Pimentel, Túlio , Righetto, Bruno Branco , Tong, Guangyu , Ferreira Félix, Iuri, Barbosa, Lucas , Ruelas, Mariano Gallo , Araújo, Beatriz, Defante, Maria Luiza Rodrigues , Mesquita, Cynthia Florêncio de , Mendes, Beatriz Ximenes , Félix, Iuri Ferreira , Rivera, André , Ferreira, Rafael Oliva Morgado , Oliveira, Helen Michaela de , Smischney, Nathan J. , Ma, Daqing

Mayo Clinic

Anaesthesia | September 1, 2025 | Volume: 81 | Issue: 2 | Pages: 274-287

10.1111/anae.16757 | PMID 40888048 Get It

Summary Introduction Postoperative delirium is a common complication following cardiac surgery. Despite its known impact on patient outcomes, effective preventative strategies remain elusive. We aimed to perform a comprehensive Bayesian network meta‐analysis of randomised controlled trials assessing the effect of pharmacological interventions on the incidence of postoperative delirium. Methods Databases were searched from inception to September 2024. Our search was updated in January 2025. Eligible studies included randomised controlled trials reporting the incidence of postoperative delirium in patients having cardiac surgery treated with pharmacological interventions. Bayesian models were used to estimate risk ratios (RR) and mean differences with 95%CrI through Markov chain Monte Carlo. Interventions were ranked using the surface under the cumulative ranking curve. Sensitivity analyses and grading of recommendations, assessment, development and evaluation assessment were conducted to evaluate the robustness and certainty of evidence. Results Seventy‐nine randomised controlled trials comprising 24,827 patients were included, with 29 pharmacological interventions compared. Dexmedetomidine combined with melatonin was the most effective intervention, reducing the incidence of postoperative delirium compared with placebo (risk ratio 0.31, 95%CrI 0.13–0.69; low certainty). Dexmedetomidine with melatonin also significantly decreased intensive care unit stay (2.4 days, 95%CrI ‐3.50–1.10) and hospital stay (1.32 days, 95%CrI ‐2.09 to ‐0.57). Other interventions, including ketamine and risperidone, showed potential efficacy but with low or very low certainty of evidence. Discussion We identified dexmedetomidine with melatonin as the most effective pharmacological strategy for preventing postoperative delirium following cardiac surgery. Whilst these findings highlight potential benefits, the low certainty of evidence underscores the need for more high‐quality primary evidence.
Participation of Women in Cardiovascular Trials From 2017 to 2023
Magalong, John Vincent , Bantayan, Nathan Ross B. , Tesoro, Nicole Ann , Milan, Mark Jason, Purewal, Vikramjit , Pine, Polyn Luz S, Lala-Trindade, Anuradha, Cheng, Susan, Gulati, Martha , Rivera, Frederick Berro , Tsai, Chieh-Mei , Lara-Breitinger, Kyla , Milan, Mark Jason D. C. , Návar, Ann Marie , Mulvagh, Sharon L. , Januzzi, James L. , Gibson, C. Michael , Cheng, Susan, Lara-Breitinger, Kyla M , Guerrero, Mayra

Mayo Clinic

JAMA Network Open | August 31, 2025 | Volume: 8 | Issue: 8 | Pages: e2529104

10.1001/jamanetworkopen.2025.29104 | PMID 40886088 Get It

Importance Cardiovascular (CV) disease is the leading cause of death globally for both men and women, yet women remain historically underrepresented in CV clinical trials, despite facing a disproportionately high burden of morbidity and mortality in many forms of CV disease. Objective To determine the representation of women across a broad range of CV trials. Evidence Review The participation of women in CV trials registered on ClinicalTrials.gov from 2017 to 2023 was systematically determined through the extraction of publicly available information. Data were extracted to identify the country of study, disease type, trial size, clinical intervention, and age of the participants. The proportion of women and the ratio of number of female to male participants (F:M ratio) were calculated for each trial. The women’s participation:prevalence ratio (PPR) was estimated for each trial based on the relative prevalence of the disease by sex in the specified region. Findings A total of 1079 registered CV trials were identified, including 1 396 104 participants, of whom 571 641 (41.0%) were women. The F:M ratio was significantly lower for studies on arrhythmia (median [IQR], 0.5), coronary heart disease (median [IQR], 0.39 [0.33-0.70]), acute coronary syndrome (median [IQR], 0.32 [0.24-0.51]), and heart failure (median [IQR], 0.51 [0.32-0.87]) but higher for obesity (median [IQR], 1.44 [1.08-4.50]) and pulmonary hypertension (median [IQR], 2.86 [1.50-3.97]) trials. The F:M ratio was higher for trials on lifestyle interventions (median [IQR], 1.51 [0.77-3.24]) than for drug trials. PPRs were low for clinical trials on coronary heart disease (median [IQR], 0.66 [0.50-0.86]), acute coronary syndrome (median [IQR], 0.79 [0.51-0.87]), and stroke (median [IQR], 0.74 [0.61-0.95]). Representation of women in CV trials varied by disease state, region, intervention, and sponsor type. Conclusions and Relevance These findings highlight both progress and persistent challenges in representation of women within CV trials. These gaps not only limit the generalizability of trial outcomes but also perpetuate inequities in evidence-based care for women with CV conditions.
A Rat Model of Second Impact Syndrome in Diffuse Traumatic Brain Injury: Evidence of Facial Hypersensitivity, Neurological and Other Behavioral Alterations, and Immunological and Histopathological Tissue Changes
Aragão, Ana Carolina A., Santos, Vito Thayson dos, Alencar, Denise, Mendes, Gabriel Cury Batista, Pontes, Lucca de, Sanchez-Garavito, Emiliano, Wilding, Hannah , Lima, Roberto C.A., Nobre, Lívia Maria Soares , Melo, Juliana, Oliveira, Denise Nunes , Rolim, Adriana, Filho, Leonardo de Macêdo , Mendes, Gabrielle, Bhanja, Debarati , Lima, Roberto Cesar, Melo, Juliana, Shlobin, Nathan A. , Sessle, Barry J. , Hawryluk, Gregory W. J.

Mayo Clinic

No container title available | August 21, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-7273712/v1 Get It

Abstract Traumatic brain injury (TBI) can lead to chronic complications, including headache and facial hypersensitivity. Second-impact syndrome (SIS), occurring when a second TBI precedes recovery from an initial injury, often causes severe long-term symptoms. Neuroinflammation is implicated, but the comprehensive pathophysiology of SIS remains unclear. This study characterized neurological/behavioral outcomes, facial nociception, plasma inflammatory markers, and central nervous system (CNS) histopathology in rat models of SIS and single mild TBI. Female Wistar rats (n = 6/group) were assigned to naïve control, sham surgery, single impact (TBI), or double impact (SIS; intervals: 1h, 24h, 3d, 7d, 14d). Mild TBI was induced using a modified Marmarou weight-drop model. Assessments (facial mechanical sensitivity via von Frey, Neurological Severity Scale (NSS), Neurobehavioral Scale (NBS)) were performed pre-injury and on days 1,3,5,7 post-injury. Plasma IL-6 and TNF-α were measured by ELISA. Histopathology (H&E) assessed CNS inflammation. All impact groups developed transient facial mechanical allodynia and acute neurobehavioral deficits (impaired NSS/NBS at day 1). SIS groups, particularly with longer intervals (≥ 24h), exhibited more prolonged facial allodynia and significant neurological deficits compared to single TBI at specific timepoints. Plasma cytokines showed minimal changes. Histopathology revealed significantly elevated CNS inflammation in both TBI and SIS groups versus controls, with SIS groups (intervals 24h-14d) showing robust responses. Repeated TBI, especially with longer recovery intervals between injuries, results in more severe and prolonged facial allodynia, neurological deficits, and CNS neuroinflammation than a single mild TBI. These findings illuminate SIS pathophysiology and underscore the critical need for protection post-concussion.
Paclitaxel neurotoxicity is triggered by epidermal EG5 dependent microtubule fasciculation and X-ROS formation
Rieger, Sandra , Hsieh, Chia-Jung , Anthony, C. Merlyn , Vlach, Mikaela , Cádiz, Antonio , Schmidt, Natalie A. , Ugo, Marie J, Sanchez, Celina Amaya , Reimonn, Cassandra, Wuchty, Stefan , Pellegrini, Adriana D., Brieger, Leah, Pappalardo, Leah G, Regan, Daniel P. , Zhao, Bowen , Dasari, Surendra , Capobianco, Enrico , Lisse, Thomas S. , Staff, Nathan P. , Xu, Xiang‐Xi , Gutierrez, Sergio, Li, Xin , Vlach, Mikaela R , Diaz, Antonio Cadiz , Schmidt, Natalie A , Amaya Sanchez, Maria Celina , Reimonn, Cassandra A , Wuchty, Stefan , Regan, Daniel P , Zhao, Bowen , Zhang, Fuwu , Howell, Caitlin , Hrstka, Sybil C , Dasari, Surendra , Capobianco, Enrico , Lisse, Thomas S , Staff, Nathan P , Xu, Mike Xiangxi , Rieger, Sandra , Hrstka, Sybil , Harrison, Benjamin J. , Gutierrez, Sergio, Li, Xin

Mayo Clinic

No container title available | August 20, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-5470731/v1 | PMID 40894047 Get It

Abstract Taxanes are frontline chemotherapeutics that stabilize microtubules, induce mitotic arrest, and drive tumor remission. However, their off-target effects in healthy tissues, most notably cutaneous axon degeneration underlying chemotherapy-induced peripheral neuropathy (CIPN), remain poorly understood. Here, we show that paclitaxel induces microtubule fasciculation in epidermal keratinocytes through the mitotic kinesin Eg5, thereby initiating CIPN. Mechanistically, paclitaxel enhances Eg5-dependent fasciculation of detyrosinated (stabilized) microtubules, which constrict and breach the nuclear lamina. This deformation triggers tension-dependent NADPH oxidase-mediated nuclear ROS (X-ROS) formation upstream of mmp13 transcription, a pathway we previously demonstrated drives sensory axon degeneration. Employing a cross-species framework spanning zebrafish, mice, human skin biopsies, and a breast adenocarcinoma cell line, we uncover a conserved paclitaxel–Eg5 mechanism leading to fasciculation of stable microtubules in both healthy epidermis and cancer cells. These findings highlight the dualistic nature of paclitaxel action and underscore the challenge of preserving anticancer efficacy while preventing neurotoxic side effects.
Post-Operative Bleed Risks Associated with Perioperative Nonsteroidal Anti-Inflammatory Drugs: A Narrative Review
Seitz, Laura Louise , Juresic, Sanny , Siegel, Leslie R. , Smith, Nathan T. , Seitz, Laura L , Siegel, Leslie

Mayo Clinic

Journal of Pain & Palliative Care Pharmacotherapy | August 19, 2025 | Volume: 39 | Issue: 4 | Pages: 518-524

10.1080/15360288.2025.2547839 | PMID 40828145 Get It

Ebstein anomaly update: the evolution of care and the revolution of surgical strategy
Jamal, Tamer, Stephens, Elizabeth H. , Swan, Elena Ashikhmina , Weatherhead, Jeffrey R, Dearani, Joseph A., Taggart, Nathan, Qureshi, M. Yasir , Swan, Elena A, Taggart, Nathaniel W. , Weatherhead, Jeffrey , Dearani, Joseph A.

Mayo Clinic

Expert Review of Cardiovascular Therapy | August 15, 2025 | Volume: 23 | Issue: 9 | Pages: 493-505

10.1080/14779072.2025.2544817 | PMID 40815234 Get It

Revealing disparities: American Indians are deferred and denied for liver transplant at a higher rate due to psychological reasons
Elmasry, Sandra , Lizaola‐Mayo, Blanca , Delafield, Nathan L. , Milam, Adam J. , Dickson, Rolland C. , Chascsa, David M. , Chascsa, David M , Lizaola-Mayo, Blanca , Milam, Adam J

Mayo Clinic

Liver Transplantation | August 12, 2025 | Volume: 32 | Issue: 2 | Pages: 278-282

10.1097/lvt.0000000000000704 | PMID 40793991 Get It

Analysis of Tumor Microenvironmental Features Between Primary and Synchronous Liver Metastases From Patients With Colorectal Cancers Using a Deep Learning Algorithm
Emiloju, Oluwadunni E. , Foster, Nathan R. , Smoot, Rory L. , Graham, Rondell P. , Pai, Rish K. , Sinicrope, Frank A. , Emiloju, Oluwadunni , Ardestani, Bahar Saberzadeh, Smoot, Rory L , Graham, Rondell P , Pai, R K , Sinicrope, Frank A , Saberzadeh-Ardestani, Bahar

Mayo Clinic

JCO Clinical Cancer Informatics | July 22, 2025 | Volume: No volume available | Issue: 9 | Pages: No page available

10.1200/cci-25-00004 | PMID 40694782 Get It

PURPOSE The development of colorectal liver metastases (CRLMs) is associated with poor prognosis, and recent data suggest that metastasis to the liver is associated with resistance to immunotherapy. We characterized the microenvironment of primary colorectal carcinomas (CRCs) relative to their synchronous CRLMs using a validated segmentation algorithm (QuantCRC) that quantifies 15 distinct morphologic tumor features. MATERIALS AND METHODS Adult patients with CRC with synchronous CRLM (N = 57) at Mayo Clinic were identified from the electronic health record. Routine tumor hematoxylin and eosin sections were digitized and reviewed for quality control. QuantCRC (Aiforia, Inc) was applied to digitized images to extract 15 GI pathologist predefined morphological features. Tumor features were compared between paired primary tumors and their synchronous CRLMs using the Wilcoxon signed-rank test overall and within subgroups. Linear regression models were used to find predictors of the paired differences in the distinct tumor morphological features. RESULTS The study included 57 patients (median age 59 years [IQR, 50-73], 51% female) with CRC primary and synchronous CRLM, and among primaries, 37 (65%) were left-sided. QuantCRC identified six of 15 morphological features that differed significantly between primaries and their CRLMs. Compared with the primary, CRLM showed reduced stroma, more high-grade tumor and necrosis, higher tumor–stromal ratio (TSR; all P < .05), and a trend toward increased tumor-infiltrating lymphocyte (TIL) density ( P = .052). Synchronous CRLM from patients with left-sided primary tumors had significantly higher TSR, percent high-grade, percent necrosis, and TIL density compared with the primary (all P values ≤0.04). Among right-sided primaries, CRLM had a significantly reduced percent mature stroma ( P = .0296) and a higher percent necrosis ( P = .0027). CONCLUSION Compared with the primary, synchronous CRLMs showed a higher TSR and increased high-grade tumor and necrosis, which are features of tumor aggressiveness and a metastatic phenotype.
Early Findings from the Multicenter RAPID Consortium on Papillary Craniopharyngiomas
Catalino, Michael P. , Pham, D. T. , Couldwell, William T. , Evans, James J., Callopy, Calen, Pacione, Donato , Suryadevara, Carter M. , Silverstein, Julie , Gardner, Paul A. , Barkhoudarian, Garni , Miranda, Juan Carlos Fernández, Benjamin, Carolina , Kshettry, Varun R. , Zada, Gabriel , Zwagerman, Nathan T. , Cheok, Stephanie , Wu, Kyle C., Little, Andrew S. , Karsy, Michael , Couldwell, William T , Chicoine, Michael , Kshettry, Varun R , Van Gompel, Jamie J , Palit, Sandhya R. , Karsy, Michael , Pham, Duy, Rennert, Robert C , Kim, Won Bae , Kim, Albert , Gompel, Jamie J. Van , Prevedello, Daniel M. , Mamelak, Adam N. , Pacult, Mark A.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | July 18, 2025 | Volume: 87 | Issue: 04 | Pages: 406-413

10.1055/a-2646-2339 | PMID 42404182 Get It

Abstract Craniopharyngiomas are rare parasellar tumors, and papillary craniopharyngiomas (PCPs) represent 8 to 20% of cases. Interim analysis of retrospective data collected from the Registry of Adenomas of the Pituitary and Related Disorders (RAPID). Fourteen U.S.-based academic skull base centers between 2011 and 2023. Patients with PCPs. Demographic, imaging, surgical, and outcome variables. Ninety-nine patients with PCPs were included. The mean age was 51.8 ± 14.7, and 57.6% were male. Most tumors showed mixed cystic/solid components (67.5%), were transinfundibular (50.0%), and were treated with an endoscopic endonasal approach (74.5%), with 51.1% demonstrating gross total resection (GTR). Pituitary stalk was preserved in 51.9%. Permanent arginine vasopressin deficiency was seen in 67.1% and was associated with pituitary stalk sacrifice (p = 0.003). Cerebrospinal fluid leak was the most common nonendocrine postsurgical, 30-day complication (9.1%), reason for return to the operating room (3.1%), and reason for 90-day readmission (8.1%). Most patients (63.9%) received no adjuvant therapy; GTR was associated with decreased radiotherapy use (p = 0.0001). BRAFV600E mutation was detected in 64/69 tumors tested, although only one patient was treated with a BRAF inhibitor. A mean follow-up of 12.3 ± 14.6 months was seen for the group. RAPID consortium enabled the largest real-world clinical information dataset for PCPs. Early findings support that GTR and stalk preservation are important to outcomes. Iterative analysis and discussion of data led to the generation of a framework for future studies to fully leverage the capabilities of multicenter registries.